Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities

Pancreatic Ductal Adenocarcinoma (PDAC) remains one of the most challenging malignancies to treat, with a complex interplay of molecular pathways contributing to its aggressive nature. Galectin-1 (Gal-1), a member of the galectin family, has emerged as a pivotal player in the PDAC microenvironment,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogut, Ana, Stojanovic, Bojan, Jovanovic, Marina, Dimitrijevic Stojanovic, Milica, Gajovic, Nevena, Stojanovic, Bojana S., Balovic, Goran, Jovanovic, Milan, Lazovic, Aleksandar, Mirovic, Milos, Jurisevic, Milena, Jovanovic, Ivan, Mladenovic, Violeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650903/
https://www.ncbi.nlm.nih.gov/pubmed/37958483
http://dx.doi.org/10.3390/ijms242115500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650903/
https://www.ncbi.nlm.nih.gov/pubmed/37958483
http://dx.doi.org/10.3390/ijms242115500

Ejemplares similares